SWIG
PALI icon

Strategic Wealth Investment Group’s Palisade Bio PALI Stock Holding History

Strategic Wealth Investment Group’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-71
Closed -$22K – 120
2022
Q2 		$22K Hold
71
– – 0.01% 134
2022
Q1 		$56K Hold
71
– – 0.01% 101
2021
Q4 		$69K Hold
71
– – 0.02% 88
2021
Q3 		$141K Hold
71
– – 0.04% 83
2021
Q2 		$216K Buy
+71
New +$322K 0.08% 76

Other funds holding PALI

ACM
Altium Capital Management New York $42M AUM
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Strategic Wealth Investment Group's PALI Position: Q3 2022 in Review

Strategic Wealth Investment Group sold out of Palisade Bio (PALI) in Q3 2022, closing a stake of 71 shares — an estimated $22K sold.

Strategic Wealth Investment Group first reported a position in PALI in Q2 2021 and held it in 5 quarters. The position peaked at $216K in Q2 2021. 26 funds tracked by Wall St. Rank hold PALI as of Q3 2022.

  • Strategic Wealth Investment Group reported no remaining Palisade Bio position as of Q3 2022 after selling out during the quarter.
  • Strategic Wealth Investment Group sold 71 Palisade Bio shares in Q3 2022, an estimated $22K.
  • Strategic Wealth Investment Group first reported a position in Palisade Bio in Q2 2021 and held it in 5 quarters.
  • Strategic Wealth Investment Group's Palisade Bio position peaked at $216K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2022.

Based on Strategic Wealth Investment Group's 13F filing for Q3 2022, filed 21 Oct 2022.